Shinva Medical Instrument Co.,Ltd. (SHA:600587)

Shinva Medical Instrument Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,475	3,188	1,689	1,567	1,351	1,105
Short-Term Investments	-	-	-	10	-	36.03
Trading Asset Securities	44.53	100.1	100.31	98.07	41.7	41.87
Cash & Short-Term Investments	2,519	3,288	1,789	1,675	1,392	1,183
Cash Growth	1.82%	83.78%	6.81%	20.32%	17.67%	-5.38%
Accounts Receivable	2,445	2,110	2,004	1,772	1,751	1,932
Other Receivables	605.41	238.49	235.97	181.24	163.04	202.09
Receivables	3,050	2,348	2,240	1,953	1,914	2,134
Inventory	3,442	3,556	3,029	2,306	2,342	2,153
Prepaid Expenses	-	0.18	0.07	0.01	-	0.25
Other Current Assets	355.84	261.95	327.01	243.2	178.17	232.25
Total Current Assets	9,367	9,454	7,385	6,177	5,827	5,702
Property, Plant & Equipment	3,076	3,013	2,526	2,396	2,471	2,798
Long-Term Investments	1,628	1,787	1,712	1,684	1,852	1,829
Goodwill	257.26	257.26	268.76	268.76	268.76	290.65
Other Intangible Assets	475.99	478.06	478.53	461.25	523.45	550.89
Long-Term Accounts Receivable	9.53	14.78	1.37	28.92	2.56	3.8
Long-Term Deferred Tax Assets	114.85	115.96	90.34	69.66	111.04	107.11
Long-Term Deferred Charges	120.04	123.33	132.28	148.63	157.38	157.13
Other Long-Term Assets	340.82	346.4	366.56	378.67	340.4	168.86
Total Assets	15,389	15,590	12,961	11,614	11,554	11,608
Accounts Payable	2,523	2,443	2,497	2,193	1,964	1,838
Accrued Expenses	199.17	508.64	450.4	333.52	285.96	262.44
Short-Term Debt	871.45	871.95	986.4	926.39	1,812	2,481
Current Portion of Long-Term Debt	52.31	28.47	59.23	94.32	-	149.15
Current Portion of Leases	-	22.82	21.39	17.34	-	5.65
Current Income Taxes Payable	100.23	31.96	32.63	67.47	87.66	44.75
Current Unearned Revenue	2,141	2,336	2,042	1,761	1,400	1,127
Other Current Liabilities	1,249	1,274	817.42	627.9	515.34	293.43
Total Current Liabilities	7,136	7,517	6,906	6,021	6,065	6,201
Long-Term Debt	139.5	137.8	96.33	58.66	412.75	465.49
Long-Term Leases	35.72	37.95	29.37	89.77	0.63	3.4
Long-Term Unearned Revenue	77.43	61.67	52.62	53.69	104.19	109.2
Long-Term Deferred Tax Liabilities	98.25	96.04	82.75	116.04	102.43	136.16
Other Long-Term Liabilities	-	19.85	6.4	6.4	10.65	-
Total Liabilities	7,487	7,870	7,174	6,345	6,696	6,915
Common Stock	606.69	466.68	411.97	406.43	406.43	406.43
Additional Paid-In Capital	2,712	3,000	1,723	1,667	1,672	1,652
Retained Earnings	4,251	3,867	3,283	2,838	2,303	2,134
Treasury Stock	-60.28	-60.28	-62.46	-	-	-
Comprehensive Income & Other	-22.83	45.08	35.49	3.48	3.87	-13.42
Total Common Equity	7,486	7,319	5,391	4,915	4,385	4,179
Minority Interest	416.62	401.21	396.27	353.72	473.52	513.52
Shareholders' Equity	7,903	7,720	5,787	5,268	4,858	4,693
Total Liabilities & Equity	15,389	15,590	12,961	11,614	11,554	11,608
Total Debt	1,099	1,099	1,193	1,186	2,225	3,105
Net Cash (Debt)	1,420	2,189	596.64	488.82	-832.56	-1,921
Net Cash Growth	-2.90%	266.96%	22.06%	-	-	-
Net Cash Per Share	2.57	3.68	1.13	0.93	-1.59	-3.64
Filing Date Shares Outstanding	606.69	606.69	606.94	535.57	528.36	528.36
Total Common Shares Outstanding	606.69	606.69	535.57	528.36	528.36	528.36
Working Capital	2,231	1,937	478.72	156.3	-238.05	-498.81
Book Value Per Share	12.34	12.06	10.07	9.30	8.30	7.91
Tangible Book Value	6,753	6,583	4,644	4,185	3,592	3,338
Tangible Book Value Per Share	11.13	10.85	8.67	7.92	6.80	6.32
Buildings	-	2,148	2,114	2,071	-	2,161
Machinery	-	1,351	1,212	1,117	-	1,020
Construction In Progress	-	739.97	304.46	122.97	-	419.97

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.